Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.40 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15948731 | 1.00 | PDE4A (0.48) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL29502274 | 1.00 | PDE4A (0.48) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL29506762 | 1.00 | PDE4A (0.48) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL4258412 | 1.00 | PDE4A (0.48) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL5919108 | 1.00 | PDE4A (0.48) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL29375023 | 1.00 | PDE4A (0.48) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL2937201 | 0.93 | PDE4A (0.58) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL9818719 | 0.93 | PDE4A (0.58) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL28085169 | 0.93 | PDE4A (0.58) | PDE4ALMNAL3MBTL1TDP1USP2 | |
| SCHEMBL11274065 | 0.91 | PDE4A (0.56) | PDE4ALMNAL3MBTL1TDP1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 162 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260041089-A1 | PLANT BIOSTIMULANT AND METHODS OF MAKING AND USING SAME | SOLUGEN, INC. (US) | 2026-02-12 | — | — | US | claimed |
| EP-4594520-A2 | COMPOSITIONS CONTAINING OLIGONUCLEOTIDES WITH THERANOSTIC APPLICATIONS | Sixfold Bioscience Ltd. (GB) | 2025-08-06 | — | — | EP | claimed |
| WO-2025151567-A1 | IMPROVED CORROSION INHIBITOR COMPOSITIONS | SOLUGEN, INC. (US) | 2025-07-17 | — | — | WO | claimed |
| US-20250178995-A1 | COMPOSITIONS AND METHODS FOR THE PRODUCTION OF GLUCARIC ACID | SOLUGEN, INC. (US) | 2025-06-05 | — | — | US | claimed |
| WO-2025097180-A1 | BIOBASED COMPOUNDS FOR POLYMER PRODUCTION | SOLUGEN, INC. (US) | 2025-05-08 | — | — | WO | claimed |
| WO-2025090691-A1 | SUGAR OXIDATION CATALYST WITH IMPROVED SELECTIVITY | SOLUGEN, INC. (US) | 2025-05-01 | — | — | WO | claimed |
| WO-2025083080-A1 | MODIFIED XYLOSE REDUCTASE AND USES THEREOF | ANNIKKI GMBH (AT) | 2025-04-24 | — | — | WO | claimed |
| EP-4541884-A1 | MODIFIED XYLOSE REDUCTASE AND USES THEREOF | Annikki GmbH (AT) | 2025-04-23 | — | — | EP | claimed |
| WO-2025076549-A1 | SMALL MOLECULE ACTIVATORS | SOLUGEN, INC. (US) | 2025-04-10 | — | — | WO | claimed |
| WO-2025042851-A1 | BIO-BASED DETERGENT BUILDER | SOLUGEN, INC. (US) | 2025-02-27 | — | — | WO | claimed |
| WO-2024036233-A2 | BLOWING AGENTS FOR FOAMED POLYMER APPLICATIONS | SOLUGEN, INC. (US) | 2024-02-15 | — | — | WO | claimed |
| EP-3146010-B1 | BINDERS | KNAUF INSULATION INC (US) | 2023-12-13 | — | — | EP | claimed |
| CN-114276187-B | Carbon-based seaweed silicon-selenium suspension fertilizer, preparation method thereof and application thereof in rice selenium-enriched cadmium reduction | 华南农业大学 | 2023-11-28 | — | — | CN | claimed |
| WO-2023081723-A1 | METHODS AND COMPOSITIONS FOR USE IN FIRE CONTROL | SOLUGEN, INC. (US) | 2023-05-11 | — | — | WO | claimed |
| WO-2022272299-A1 | NONFERROUS METAL CORROSION INHIBITORS AND METHODS OF USING SAME | SOLUGEN, INC. (US) | 2022-12-29 | — | — | WO | claimed |
| CN-114858947-A | Detection method of alpha-dicarbonyl compound and application thereof | 湖南师范大学 | 2022-08-05 | — | — | CN | claimed |
| EP-0631569-B1 | PRODUCTION OF XYLITOL | AMYLUM NV (BE) | 1997-06-18 | — | — | EP | claimed |
| US-5563303-A | Production of xylitol | AMYLUM, N.V. (BE) | 1996-10-08 | — | — | US | claimed |
| EP-0631569-A1 | PRODUCTION OF XYLITOL. | AMYLUM NV (BE) | 1995-01-04 | — | — | EP | claimed |
| WO-1993019030-A1 | PRODUCTION OF XYLITOL | AMYLUM, N.V. (BE) | 1993-09-30 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250178995-A1 | COMPOSITIONS AND METHODS FOR THE PRODUCTION OF GLUCARIC ACID | G6PD, SOD1, UGDH | PDE4A 4213/4885LMNA 4834/4885L3MBTL1 3188/4885 |
| US-20260041089-A1 | PLANT BIOSTIMULANT AND METHODS OF MAKING AND USING SAME | GMDS, ALG1, PGD | PDE4A 3046/4885LMNA 1352/4885L3MBTL1 2626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.